POY_1170x120_8-12-19

Aromasin

Mylan releases Aromasin generic in U.S.

Mylan releases Aromasin generic in U.S.

PITTSBURGH — Mylan N.V. has launched exemestane tablets 25 mg, a breast cancer medication, in the United States. Mylan said its exemestane product is a generic version of Aromasin tablets from Pfizer Inc. Exemestane is indicated for the treatment of certain types of breast cancer in women after menopause. The medication works by reducing estrogen